Skip to main content
. Author manuscript; available in PMC: 2015 Apr 15.
Published in final edited form as: Gynecol Oncol. 2008 Oct 16;112(1):104–109. doi: 10.1016/j.ygyno.2008.08.028

Table 1.

Patient Characteristics at Initial Diagnosis Asymptomatic* (n=78) Symptomatic* (n=25)
Median age (range) 50 (27-84) 46 (26-64)
Stage
    Ib1 15 (19%) 0 (0%)
    Ib2 17 (13%) 6 (24%)
    IIa 1 (1%) 0 (0%)
    IIb 28 (36%) 11 (44%)
    IIIb 25 (32%) 8 (32%)
Histology
    Squamous 70 (90%) 23 (92%)
    Adenocarcinoma 5 (6%) 2 (4%)
    Other 3 (4%) 0 (0%)
Pre treatment lymph nodes positive
    Aortic 9 (12%) 1 (4%)
    Pelvic 31 (40%) 13 (52%)
    None 38 (49%) 11 (44%)
Duration of follow up (months) 13 8
*

Symptom status refers to first surveillance FDG-PET